Stanniocalcin 2 (STC2): a universal tumour biomarker and a potential therapeutical target
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-9966
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Stanniocalcin 2 (STC2): a universal tumour biomarker and a potential therapeutical target ; volume:41 ; number:1 ; day:2 ; month:5 ; year:2022 ; pages:1-19 ; date:12.2022
Journal of experimental & clinical cancer research ; 41, Heft 1 (2.5.2022), 1-19, 12.2022
- Creator
-
Qie, Shuo
Sang, Nianli
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13046-022-02370-w
- URN
-
urn:nbn:de:101:1-2022071021514928866760
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:26 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Qie, Shuo
- Sang, Nianli
- SpringerLink (Online service)
Other Objects (12)
Tumour macrophages as potential targets of bisphosphonates
CCT3 acts upstream of YAP and TFCP2 as a potential target and tumour biomarker in liver cancer
Correction: CCT3 acts upstream of YAP and TFCP2 as a potential target and tumour biomarker in liver cancer
MIA is a potential biomarker for tumour load in neurofibromatosis type 1
Circular RNA in Retina: A Potential Biomarker and Therapeutic Target
NEK2 is a potential pan-cancer biomarker and immunotherapy target
Small Dense Low-Density Lipoprotein: Biomarker or Potential Drug Target?
B-cell immune checkpoint TIM-1: a potential target for tumour immunotherapy
Glutamine metabolism as a potential biomarker and target for cancer radiosensitization
NAT10 as a potential prognostic biomarker and therapeutic target for HNSCC
Tumour-stroma ratio outperforms tumour budding as biomarker in colon cancer: a cohort study
Leukemia Inhibitory Factor: A Potential Biomarker and Therapeutic Target in Pancreatic Cancer
Tumour macrophages as potential targets of bisphosphonates
CCT3 acts upstream of YAP and TFCP2 as a potential target and tumour biomarker in liver cancer
Correction: CCT3 acts upstream of YAP and TFCP2 as a potential target and tumour biomarker in liver cancer
MIA is a potential biomarker for tumour load in neurofibromatosis type 1
Circular RNA in Retina: A Potential Biomarker and Therapeutic Target
NEK2 is a potential pan-cancer biomarker and immunotherapy target
Small Dense Low-Density Lipoprotein: Biomarker or Potential Drug Target?
B-cell immune checkpoint TIM-1: a potential target for tumour immunotherapy
Glutamine metabolism as a potential biomarker and target for cancer radiosensitization
NAT10 as a potential prognostic biomarker and therapeutic target for HNSCC
Tumour-stroma ratio outperforms tumour budding as biomarker in colon cancer: a cohort study
Leukemia Inhibitory Factor: A Potential Biomarker and Therapeutic Target in Pancreatic Cancer
Tumour macrophages as potential targets of bisphosphonates
CCT3 acts upstream of YAP and TFCP2 as a potential target and tumour biomarker in liver cancer
Correction: CCT3 acts upstream of YAP and TFCP2 as a potential target and tumour biomarker in liver cancer
MIA is a potential biomarker for tumour load in neurofibromatosis type 1
Circular RNA in Retina: A Potential Biomarker and Therapeutic Target
NEK2 is a potential pan-cancer biomarker and immunotherapy target
Small Dense Low-Density Lipoprotein: Biomarker or Potential Drug Target?
B-cell immune checkpoint TIM-1: a potential target for tumour immunotherapy
Glutamine metabolism as a potential biomarker and target for cancer radiosensitization
NAT10 as a potential prognostic biomarker and therapeutic target for HNSCC
Tumour-stroma ratio outperforms tumour budding as biomarker in colon cancer: a cohort study